European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases.

News & Events

Action Videos

Action in Numbers

Countries Involved
ITC & Near Neighbour Countries


COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.

Action CA 21147

Although treatment of chronic inflammatory diseases has been revolutionised with the introduction of targeted therapies with therapeutic antibodies, a large portion of patients do not respond to treatment or they lose response over time. This is mainly attributed to suboptimal dosing, immunogenicity and interpatient variability in pharmacokinetics.

Action Details

CSO Approval date – 27/05/2022
Start date – 03/11/2022
End date – 02/11/2026